ApoGlyx AB
About
Developing small molecule inhibitors for inflammatory diseases
TECHNOLOGY AREAS
Life science (Healthcare)
Representatives
Michael Rützler
ApoGlyx AB
Developing small molecule inhibitors for inflammatory diseases
TECHNOLOGY AREAS
ApoGlyx AB